{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:57Z","timestamp":1792382937770,"version":"4.4.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01648","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T05:33:51Z","timestamp":1594359231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":432,"title":["Cytokine Storm in COVID-19\u2014Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper"],"prefix":"10.3389","volume":"11","author":[{"given":"Sonu","family":"Bhaskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akansha","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Mittoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Weissert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama R.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Kutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e201017","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-020-0305-6","article-title":"In the eye of the COVID-19 cytokine storm","volume":"20","author":"Vaninov","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40674-017-0059-x","article-title":"Weathering the storm: improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis","volume":"3","author":"Weaver","year":"2017","journal-title":"Curr Treatm Opt Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5114\/aoms.2020.94503","article-title":"Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic","volume":"16","author":"Katsiki","year":"2020","journal-title":"Arch Med Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/s0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1172\/jci138871","article-title":"Kidney diseases in the time of COVID-19: major challenges to patient care","volume":"130","author":"Rabb","year":"2020","journal-title":"J Clin Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000507305","article-title":"Should COVID-19 concern nephrologists? why and to what extent? the emerging impasse of angiotensin blockade","volume":"144","author":"Perico","year":"2020","journal-title":"Nephron."},{"key":"B14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fcvm.2020.00112","article-title":"Key strategies for clinical management and improvement of healthcare services for cardiovascular disease and diabetes patients in the coronavirus (COVID-19) settings: recommendations from the REPROGRAM Consortium","volume":"7","author":"Bhaskar","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"104891","DOI":"10.1016\/j.phrs.2020.104891","article-title":"Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic","volume":"158","author":"Banach","year":"2020","journal-title":"Pharmacol Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch Med Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/s0140-6736(20)30912-0","article-title":"Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes","volume":"395","author":"Doyen","year":"2020","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0107","DOI":"10.1097\/CCE.0000000000000107","article-title":"Neurologic manifestations of severe respiratory viral contagions","volume":"2","author":"Robinson","year":"2020","journal-title":"Crit Care Explor."},{"key":"B21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1212\/wnl.0000000000009455","article-title":"Neurologic complications of coronavirus infections","volume":"94","author":"Nath","year":"2020","journal-title":"Neurology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fneur.2020.00579","article-title":"Acute neurological care in the COVID-19 era: the pandemic health system REsilience PROGRAM (REPROGRAM) consortium pathway","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fneur.2020.00664","article-title":"Chronic neurology in COVID-19 era: clinical considerations and recommendations from the REPROGRAM Consortium","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2020.05.18.20099960","DOI":"10.1101\/2020.05.18.20099960","article-title":"Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience","author":"Bryce","year":"2020","journal-title":"medRxiv."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological features of Covid-19","author":"Solomon","year":"2020","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","article-title":"Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","volume":"92","author":"Paniz-Mondolfi","year":"2020","journal-title":"J Med Virol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26046","article-title":"Is the brain a reservoir organ for SARS-CoV2?","author":"Gomez-Pinedo","year":"2020","journal-title":"J Med Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S0140-6736(20)31282-4","article-title":"Early evidence of pronounced brain involvement in fatal COVID-19 outcomes","volume":"395","author":"von Weyhern","year":"2020","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jinf.2020.03.019","article-title":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up","volume":"80","author":"Wang","year":"2020","journal-title":"J Infect."},{"key":"B32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","article-title":"Immunosenescence: emerging challenges for an ageing population","volume":"120","author":"Aw","year":"2007","journal-title":"Immunology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41514-017-0020-0","article-title":"Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging","volume":"4","author":"Del Giudice","year":"2017","journal-title":"npj Aging Mech Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12979-019-0165-8","article-title":"Age related human T cell subset evolution and senescence","volume":"16","author":"Li","year":"2019","journal-title":"Immun Ageing."},{"key":"B35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28 T cells: their role in the age-associated decline of immune function","volume":"30","author":"Weng","year":"2009","journal-title":"Trends Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1189\/jlb.3RI0716-335R","article-title":"Human T cell immunosenescence and inflammation in aging","volume":"102","author":"Bektas","year":"2017","journal-title":"J Leukoc Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.immunol.21.120601.141114","article-title":"CD8 T cell responses to infectious pathogens","volume":"21","author":"Wong","year":"2003","journal-title":"Annu Rev Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/ad.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10555-020-09889-4","article-title":"Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?","volume":"39","author":"Panigrahy","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: faraway, so close!","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41435-020-0098-4","article-title":"The genetics of macrophage activation syndrome","volume":"21","author":"Schulert","year":"2020","journal-title":"Genes Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol."},{"key":"B43","first-page":"1","article-title":"Neuroimmune signaling: cytokines and the CNS","volume-title":"Neuroscience in the 21st Century","author":"Kennedy","year":"2016"},{"key":"B44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1053\/j.gastro.2020.02.054","article-title":"COVID-19: gastrointestinal manifestations and potential fecal\u2013oral transmission","volume":"158","author":"Gu","year":"2020","journal-title":"Gastroenterology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/s2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3389\/fimmu.2018.03022","article-title":"Fine tuning the cytokine storm by IFN and IL-10 following neurotropic coronavirus encephalomyelitis","volume":"9","author":"Savarin","year":"2018","journal-title":"Front Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s11064-014-1409-9","article-title":"Brain-derived neurotrophic factor and interleukin-6 levels in the serum and cerebrospinal fluid of children with viral infection-induced encephalopathy","volume":"39","author":"Morichi","year":"2014","journal-title":"Neurochem Res."},{"key":"B52","unstructured":"ESC Guidance for the Diagnosis and Management of CV Disease During the COVID-19 Pandemic"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200823","article-title":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT","author":"Bai","year":"2020","journal-title":"Radiology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.acra.2020.03.028","article-title":"CT Manifestation of COVID-19 Pneumonia; role of multiplanar imaging","volume":"27","author":"Ostad","year":"2020","journal-title":"Acad Radiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S1473-3099(20)30134-1","article-title":"COVID-19 pneumonia: what has CT taught us?","volume":"20","author":"Lee","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2214\/AJR.20.22976","article-title":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) Pneumonia: a multicenter study","volume":"214","author":"Zhao","year":"2020","journal-title":"Am J Roentgenol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.003","article-title":"The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society","author":"Rubin","year":"2020","journal-title":"Chest."},{"key":"B59","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1148\/radiol.2020200370","article-title":"Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19)","volume":"295","author":"Pan","year":"2020","journal-title":"Radiology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.crad.2020.03.003","article-title":"An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement","volume":"75","author":"Rodrigues","year":"2020","journal-title":"Clin Radiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of Covid-19 in the young","volume":"382","author":"Oxley","year":"2020","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00134-020-06040-3","article-title":"Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening","volume":"46","author":"Tavazzi","year":"2020","journal-title":"Intensive care Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2020.04.06.20050575","DOI":"10.1101\/2020.04.06.20050575","article-title":"Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans","author":"Fox","year":"2020","journal-title":"medRxiv."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/bjh.16725","article-title":"Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"189","author":"Xiong","year":"2020","journal-title":"Br J Haematol."},{"key":"B70","unstructured":"COVID-19 and VTE\/Anticoagulation: Frequently Asked Questions"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1097\/CCM.0b013e31828cf104","article-title":"Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ctro.2020.03.009","article-title":"COVID-19: Global radiation oncology's targeted response for pandemic preparedness","volume":"22","author":"Simcock","year":"2020","journal-title":"Clin Transl Radiat Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(20)30217-5","article-title":"Cancer guidelines during the COVID-19 pandemic","volume":"21","author":"Burki","year":"2020","journal-title":"Lancet Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.radonc.2019.06.037","article-title":"Single vs multiple fraction palliative radiation therapy for bone metastases: cumulative meta-analysis","volume":"141","author":"Chow","year":"2019","journal-title":"Radiother Oncol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5694\/mja2.50607","article-title":"Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance","volume":"212","author":"Weinkove","year":"2020","journal-title":"Med J Aust."},{"key":"B76","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3904\/kjim.2018.036","article-title":"Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea","volume":"33","author":"Cho","year":"2018","journal-title":"Korean J Intern Med."},{"key":"B77","unstructured":"COVID-19: Special Considerations for People Living With HIV"},{"key":"B78","unstructured":"GoldenbergDL How Clinicians Can Manage Rheumatic and Immune Diseases During COVID-19"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.7196\/samj.2015.v105i12.10220","article-title":"Infections in the management of rheumatic diseases: an update","volume":"105","author":"Botha-Scheepers","year":"2015","journal-title":"S Afr Med J."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/art.41301","article-title":"American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 1","author":"Mikuls","year":"2020","journal-title":"Arthrit Rheumatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2020-217628","article-title":"Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2\/COVID-19 pandemic","volume":"79","author":"Schulze-Koops","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B82","unstructured":"MSAustralia COVID-19 Information for People With MS"},{"key":"B83","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/emp2.12081","article-title":"COVID-19: a review of therapeutics under investigation","volume":"1","author":"Crosby","year":"2020","journal-title":"J Am Coll Emerg Physicians Open."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/s0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann","year":"2020","journal-title":"Lancet."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.12688\/f1000research.9092.1","article-title":"Agents to reduce cytokine storm","volume":"5","author":"Gerlach","year":"2016","journal-title":"F1000Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"102538","DOI":"10.1016\/j.autrev.2020.102538","article-title":"Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning","volume":"19","author":"Shoenfeld","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B87","first-page":"634","article-title":"ACEIs for cardiovascular risk reduction\u2013have we taken our eye off the ball?","volume":"42","author":"Sindone","year":"2013","journal-title":"Aust Fam Physician."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/molecules25092076","article-title":"Pharmacological (or synthetic) and nutritional agonists of PPAR-\u03b3 as candidates for cytokine storm modulation in COVID-19 disease","author":"Ciavarella","year":"2020","journal-title":"Molecules."},{"key":"B90","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.arcmed.2020.04.006","article-title":"Oleoylethanolamide, a bioactive lipid amide, as a promising treatment strategy for coronavirus\/COVID-19","volume":"51","author":"Ghaffari","year":"2020","journal-title":"Arch Med Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1750-2659.2010.00155.x","article-title":"Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice","volume":"4","author":"Moseley","year":"2010","journal-title":"Influenza Other Respir Viruses."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00592-019-01369-8","article-title":"The healthy Nordic diet for blood glucose control: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"57","author":"Zimorovat","year":"2020","journal-title":"Acta Diabetol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5582\/bst.2020.03058","article-title":"Macrolide treatment for COVID-19: will this be the way forward?","volume":"14","author":"Ohe","year":"2020","journal-title":"Biosci Trends."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/aps.2013.54","article-title":"Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol Sin."},{"key":"B95","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1084\/jem.20030351","article-title":"A critical role for OX40 in T cell-mediated immunopathology during lung viral infection","volume":"198","author":"Humphreys","year":"2003","journal-title":"J Exp Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.apsb.2019.08.010","article-title":"Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity","volume":"10","author":"Fu","year":"2020","journal-title":"Acta Pharm Sin B."},{"key":"B98","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.redar.2020.03.004","article-title":"Dos terapias conocidas podr\u00edan ser efectivas como adyuvantes en el paciente cr\u00edtico infectado por COVID-19","author":"Hern\u00e1ndez","year":"2020","journal-title":"Rev Espa\u00f1ola Anestesiol Reanimaci\u00f3n."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e1004134","DOI":"10.1371\/journal.ppat.1004134","article-title":"Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection","volume":"10","author":"Kedzierski","year":"2014","journal-title":"PLoS Pathog."},{"key":"B100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40560-017-0208-1","article-title":"Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient","volume":"5","author":"David","year":"2017","journal-title":"J Intensive Care."},{"key":"B101","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41581-020-0284-7","article-title":"Kidney involvement in COVID-19 and rationale for extracorporeal therapies","volume":"16","author":"Ronco","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0345-7","article-title":"Inflammation-induced inhibition of chaperone-mediated autophagy maintains the immunosuppressive function of murine mesenchymal stromal cells","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/en.2011-0249","article-title":"Diacerhein improves glucose tolerance and insulin sensitivity in mice on a high-fat diet","volume":"152","author":"Tobar","year":"2011","journal-title":"Endocrinology."},{"key":"B105","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40266-016-0347-4","article-title":"Diacerein: benefits, risks and place in the management of osteoarthritis. an opinion-based report from the ESCEO","volume":"33","author":"Pavelka","year":"2016","journal-title":"Drugs Aging."},{"key":"B106","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/cts.12606","article-title":"Tranilast Treatment Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through the Inhibition of Inflammatory Responses Mediated by NF-\u03baB and PPARs","volume":"12","author":"Zhuo","year":"2019","journal-title":"Clin Transl Sci."},{"key":"B107","unstructured":"COVID-19 Registered Trials - and Analysis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-015-0049-9","article-title":"Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin","volume":"5","author":"Ouellette","year":"2015","journal-title":"Ann Intensive Care."},{"key":"B109","unstructured":"FDA Cautions Against Use of Hydroxychloroquine or Chloroquine for COVID-19 Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems"},{"key":"B110","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.4049\/jimmunol.1202434","article-title":"Altered T-bet dominance in IFN-\u03b3-decoupled CD4+ T cells with attenuated cytokine storm and preserved memory in influenza","volume":"190","author":"Dutta","year":"2013","journal-title":"J Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B112","doi-asserted-by":"crossref","DOI":"10.31219\/osf.io\/3gwmp","article-title":"Scavenging of interleukin 6 receptor by bioidentical recombinant Gp130 as intervention in Covid-19 exacerbation","volume-title":"OSF Preprints","author":"Lobentanzer","year":""},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B114","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/s1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact","author":"Cantini","year":"2020","journal-title":"J Infect"},{"key":"B116","doi-asserted-by":"publisher","first-page":"S0012-3692(20)30710-8","DOI":"10.1016\/j.chest.2020.04.010","article-title":"Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China","author":"Chen","year":"2020","journal-title":"Chest."},{"key":"B117","unstructured":"Massachusetts General Hospital (MGH) COVID-19 Treatment Guidance"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B120","unstructured":"Approach to Immunosuppression in Severe COVID-19"},{"key":"B121","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12969-019-0309-6","article-title":"Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome","volume":"17","author":"Halyabar","year":"2019","journal-title":"Pediatr Rheumatol Online J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1097\/ccm.0000000000004363","article-title":"Surviving sepsis campaign: guidelines on the management of critically Ill adults with coronavirus disease 2019 (COVID-19)","volume":"48","author":"Alhazzani","year":"2020","journal-title":"Crit Care Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nrleng.2020.04.002","article-title":"Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?","volume":"35","author":"Serrano-Castro","year":"2020","journal-title":"Neurolog\u00eda."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2020.03.13.990226","DOI":"10.1101\/2020.03.13.990226","article-title":"Reinfection could not occur in SARS-CoV-2 infected rhesus macaques","author":"Bao","year":"2020","journal-title":"bioRxiv."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01648\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T05:25:33Z","timestamp":1667366733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01648\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2020.01648"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01648","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"article-number":"1648"}}